Related Experiment Video
Updated: Jun 29, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Real-life management of patients with mild cognitive impairment: an Italian survey
Laura Bonanni1, Annachiara Cagnin2, Claudia Carrarini3,4
1Neurology Clinic, Department of Medicine and Aging Sciences, University G. D'Annunzio of Chieti-Pescara, Chieti, Italy.
Background:
Mild cognitive impairment (MCI) is a syndrome with heterogeneous underlying causes and different rates of disease progression, whose clinical heterogeneity leads to a wide variation in diagnostic and therapeutic approaches in clinical practice. The lack of uniform practical recommendations on diagnostic workup and treatment for MCI patients hinders optimal management of these patients, worsening their prognosis. Standardized guidelines for the investigation and follow-up of MCI are therefore urgently required.
Aim:
Aim of our study was to assess the diagnostic and therapeutic approach to MCI patients in the setting of Italian Memory Clinics.
Methods:
A survey was delivered to a sample of Italian neurologists through two different phases: a first exploratory phase recording general information about the usual clinical management of patients with MCI, and a subsequent operative phase assessing the practical diagnostic and therapeutic decisions taken in a real life setting to manage subjects with MCI.
Results:
A total of 121 neurologists participated to the first phase of the survey and 203 patients were enrolled in the second phase. Information gathered in the first phase of the survey highlighted a non-uniform use of diagnostic criteria and procedures for MCI, as well as a very heterogeneous therapeutic strategy among Italian neurologists. In the second phase, recorded data on diagnostic and therapeutic approach confirmed the large variability observed in the first phase of the survey.
Conclusions:
The results of our study reflect a suboptimal management of MCI patients in Italy and highlight the need of standardized diagnostic and therapeutic approaches for this condition.
Insights
Management of mild cognitive impairment (MCI) in Italy is suboptimal due to non-uniform diagnostic and therapeutic strategies. Standardized approaches are urgently needed to improve patient prognosis and care for this heterogeneous condition.
Area of Science:
- Neurology
- Geriatrics
- Clinical Medicine
Background:
- Mild cognitive impairment (MCI) presents with diverse causes and progression rates.
- Clinical heterogeneity of MCI leads to varied diagnostic and therapeutic practices.
- Lack of uniform recommendations hinders optimal MCI patient management and prognosis.
Purpose of the Study:
- To evaluate the diagnostic and therapeutic strategies for MCI patients in Italian Memory Clinics.
- To identify variations in clinical management of MCI across different centers.
Main Methods:
- A two-phase survey was administered to Italian neurologists.
- Phase 1 explored general clinical management of MCI.
- Phase 2 assessed real-life diagnostic and therapeutic decisions for MCI patients.
Main Results:
- 121 neurologists participated in Phase 1; 203 patients in Phase 2.
- Non-uniform diagnostic criteria and heterogeneous therapeutic strategies were observed.
- Data confirmed significant variability in MCI management.
Conclusions:
- Current management of MCI patients in Italy is suboptimal.
- There is a critical need for standardized diagnostic and therapeutic approaches for MCI.
- Standardization is essential to improve outcomes for individuals with MCI.
Related Concept Videos
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Management of Insomnia

